Depression and psoriasis;Dépression et psoriasis

Annales de Dermatologie et de Venereologie

Volumn 135, Issue SUPPL. 4, 2008, Pages 254-258

  Bougueon K ^a   Misery, L ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Alexithymia; Bipolar disorder; Depression; Psoriasis; TNF

Indexed keywords

SEROTONIN; SUBSTANCE P; TUMOR NECROSIS FACTOR;

ARTICLE; BIPOLAR DISORDER; COMORBIDITY; DEPRESSION; EARLY DIAGNOSIS; MENTAL DISEASE; PSORIASIS; QUALITY OF LIFE; HUMAN; PSYCHOLOGICAL ASPECT; REVIEW;

BIPOLAR DISORDER; COMORBIDITY; DEPRESSION; HUMANS; PSORIASIS; QUALITY OF LIFE;

EID: 48849108760     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(08)70544-1     Document Type: Article

References (28)

1. Yong Y., Koh D., Khoo L., Nyunt S.Z., Vivian N.G., and Goh C.L. The psoriasis disability index in chinese patients: contribution of clinical and psychological varaibles. Int J Dermatol 44 (2005) 925-929
2. Richards H.L., Fortune D.G., Griffiths C.E.M., and Main C.J. The contribution of stigmatisation to disability in patients with psoriasis. J Psychosom Res 50 (2001) 11-15
3. Gupta M.A., and Gupta A.K. Psychiatric and psychological co-morbidity in patients with dermatologic disorders. Am J Clin Dermatol 4 (2003) 833-842
4. Fortune D.G., Richards H.L., and Griffiths C.E.M. Psychologic factors in psoriasis: consequences, mechanisms and interventions. Dermatol Clin 23 (2005) 681-694
5. Consoli S.G. Psoriasis et dépression. Bull Eur Dermatol Cosmetol 11 (2003) 88-90
6. Devrimci-Ozguven H., Kundakci N., Kumbasar H., and Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 14 (2000) 267-271
7. Scharloo M., Kaptein A.A., and Weinman J. Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol 142 (2000) 899-907
8. Gupta M.A., and Gupta A.K. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 139 (1998) 846-850
9. Fortune D.G., Richards H.L., and Mc Eelhone K. Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being. Br J Dermatol 151 (2004) 1219-1226
10. Fortune D.G., Richards H.L., and Grifftihs C.E.M. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 41 (2002) 157-174
11. Esposito M., Saraceno R., Giunta A., Maccarone M., and Chimenti S. An italian study on psoriasis and depression. Dermatology 212 (2006) 123-127
12. Gupta M.A., Gupta A.K., Ellis C.N., and Voorhees J. Some psychosomatic aspects of psoriasis. Adv Dermatol 5 (1990) 21-32
13. Ginsburg I.H. Psychological and psychophysiological aspects of psoriasis. Dermatol Clin 13 (1995) 793-801
14. Schmitt J.M., and Ford D.E. Role of depression in quality of life for patients with psoriasis. Dermatology 215 (2007) 17-27
15. Schmitt J.M., and Ford D.E. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis- a structural equations modeling approach. Gen Hosp Psychiatry 29 (2007) 134-140
16. Cohen A.D., Ofek-Shomai A., Vardy D.A., Weiner Z., and Scvartzman P. Depression in dermatological patients identified by the MINI international neuropsychiatric interview questionnaire. J Am Acad Dermatol 54 (2006) 94-99
17. Bougueon K. Troubles bipolaires et psoriasis. Thèse de Médecine, Université de Bretagne Occidentale;11 Oct 2006; 121 pages.
18. Meyer N., and Roman P. Psoriasis et alcool. Ann Dermatol Venereol 130 (2003) 409-412
19. Bertagne P., Pedinielli J.L., and Marlière C. L'alexithymie : évaluation, données quantitatives et cliniques. L'Encéphale XVIII (1992) 121-130
20. Allengranti I., Gon T., Magaton-Rizzi G., and Aguglia E. Prevalence of alexithymic characteristics in psoriatic patients. Acta Derm Venereol 186 (1994) 146-147
21. Honkalampi A., Hintikka J., Tansknen A., Lehtonen J., and Viinamaki H. Depression is strongly associated with alexithymie in the general population. J Psychosom Res 48 (2000) 99-104
22. Consoli S.M., Rolhion S., Martin C., Ruel K., Cambazard F., Pellet J., et al. Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis. Dermatology 212 (2006) 128-136
23. Misery L. Skin, immunity and the nervous system. Br J Dermatol 137 (1997) 843-850
24. Saraceno R., Kleyn C.E., Terenghi G., and Griffiths C.E.M. The role of neuropeptides in psoriasis. Br J Dermatol 154 (2006) 876-882
25. Nordlind K., Thorslund K., Lonne-Rahm S., Mohabbati S., Berki T., Morales M., et al. Expression of serotoninergic receptors in psoriatic skin. Arch Dermatol Res 298 (2006) 99-106
26. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., and Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9 (2008) 46-56
27. Tyring S., Gottlieb A., Papp K., Gordon K., Leonardi C., Wang A., et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomized phase III trial. Lancet 367 (2006) 29-35
28. Krishnan R., Cella D., Leonardi C., Papp K., Gottlieb A.B., Dunn M., et al. Effects of etarnecept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol 157 (2007) 1275-1277